Skip to main content
Clinical Trials/NCT01723046
NCT01723046
Unknown
Not Applicable

Active Smart Wearable Orthosis Using Painted EMG Electrodes for Home Based Therapy With Augmentative Feedback

Thomas More Kempen1 site in 1 country10 target enrollmentFebruary 2013
ConditionsStroke

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stroke
Sponsor
Thomas More Kempen
Enrollment
10
Locations
1
Primary Endpoint
Active range of motion of the elbow joint
Last Updated
13 years ago

Overview

Brief Summary

The purpose of this pilot study is to investigate the clinical effects of a new upper limb robot assisted therapy device that is linked to a virtual therapy environment in patients with stroke.

Detailed Description

The number of physically weak individuals is increasing, resulting in a higher burden on health care and health care workers. The use of robot assisted therapy (RAT) might partly solve this problem. Rehabilitation progress highly depends on training intensity and training duration, favouring the use of RAT. In this pilot study, the clinical effects of using a new upper arm RAT device for upper arm rehabilitation in patients with stroke is investigated. Myo-electrical signals will serve as input for the device, assisting the user in flexion and extension of the elbow. The device is coupled to a virtual environments, creating a stimulating therapy environment.

Registry
clinicaltrials.gov
Start Date
February 2013
End Date
September 2014
Last Updated
13 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Lore Van de Perre

Study principal investigator

Thomas More Kempen

Eligibility Criteria

Inclusion Criteria

  • Patients with stroke, more than three months post onset
  • No or moderate spasticity in the upper limb (maximum score of 3 on Modified Ashworth Scale)
  • Observable voluntary muscle activity in biceps and triceps muscle of the affected upper limb (minimal score of 1 on the Medical research council score)
  • Able to sit on a chair with adequate trunk stability
  • Able to follow verbal instructions
  • Able to communicate verbal information to the researchers

Exclusion Criteria

  • Patients who are medically unstable
  • Cognitive disorders impeding the intervention
  • Visual disorders impeding the intervention
  • Subluxation of the shoulder joint
  • Pusher syndrome

Outcomes

Primary Outcomes

Active range of motion of the elbow joint

Time Frame: Change from baseline active range of motion of the elbow joint at 8 weeks and 12 weeks

The maximum range of motion to flexion and extension of the elbow joint that the person can achieve independently

Passive range of motion of the elbow joint

Time Frame: Change from baseline passive range of motion of the elbow joint at 8 weeks and 12 weeks

The maximum range of motion to flexion and extension of the elbow joint of the test person that can be achieved by the assessor.

Modified Ashworth Scale

Time Frame: Change from baseline Modified Ashworth Scale at 8 weeks and 12 weeks

Spasticity measurement

Fugl-Meyer test upper limb section

Time Frame: Change from baseline Fugl-Meyer test upper limb section at 8 weeks and 12 weeks

Stroke specific, performance based impairment index. Applied to determine disease severity and describe motor recovery.

Medical research council score

Time Frame: Change from baseline Medical research council score at 8 weeks and 12 weeks

Muscle strength assessment

Secondary Outcomes

  • ABILHAND questionnaire(Change from baseline ABILHAND questionnaire score at 8 weeks and 12 weeks)
  • Functional independence measure(Change from baseline Functional independence measure score at 8 weeks and 12 weeks)
  • Stroke impact scale(Change from baseline Stroke impact scale score at 8 weeks and 12 weeks)
  • Intrinsic motivation inventory(Change from baseline Intrinsic motivation inventory score at 8 weeks and 12 weeks)

Study Sites (1)

Loading locations...

Similar Trials